{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T02:06:11Z","timestamp":1770516371488,"version":"3.49.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the National Research and Development Plan of China","award":["Grant No. 2018YFE0121600"],"award-info":[{"award-number":["Grant No. 2018YFE0121600"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochem Genet"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s10528-025-11022-5","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T03:17:17Z","timestamp":1737515837000},"page":"286-303","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Haplotypes of Chloroquine Resistance Marker Genes Among Uncomplicated Malaria Cases in Lagos, Nigeria"],"prefix":"10.1007","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8424-6838","authenticated-orcid":false,"given":"Uche Thecla","family":"Igbasi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wellington Aghoghavia","family":"Oyibo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Hu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Quan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunday Aremu","family":"Omilabu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shen-Bo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Mo","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Nong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,22]]},"reference":[{"key":"11022_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.34172\/ajcmi.3524","volume":"11","author":"A Abubakar Zubair","year":"2024","unstructured":"Abubakar Zubair A, Ajibade G, Haroun A et al (2024) Molecular surveillance of artemisinin combination therapy resistance markers in Kelch13 gene of plasmodium falciparum isolates collected from Yobe State Nigeria. Avicenna J Clin Microbiol Infect 11:87\u201396. https:\/\/doi.org\/10.34172\/ajcmi.3524","journal-title":"Avicenna J Clin Microbiol Infect"},{"key":"11022_CR2","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1473-3099(15)00487-9","volume":"16","author":"C Amaratunga","year":"2016","unstructured":"Amaratunga C, Lim P, Suon S et al (2016) Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study. Lancet Infect Dis 16:357\u2013365. https:\/\/doi.org\/10.1016\/S1473-3099(15)00487-9","journal-title":"Lancet Infect Dis"},{"key":"11022_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.molbiopara.2007.09.008","author":"LE Amoah","year":"2008","unstructured":"Amoah LE, Lekostaj JK, Roepe PD (2008) A single S1034C mutation confers altered drug sensitivity to PfMDR1 ATPase activity that is characteristic of the 7G8 isoform. Mol Biochem Parasitol. https:\/\/doi.org\/10.1016\/j.molbiopara.2007.09.008","journal-title":"Mol Biochem Parasitol"},{"key":"11022_CR4","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1314981","volume":"371","author":"EA Ashley","year":"2014","unstructured":"Ashley EA, Dhorda M, Fairhurst RM et al (2014) Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 371:411\u2013423. https:\/\/doi.org\/10.1056\/NEJMoa1314981","journal-title":"N Engl J Med"},{"key":"11022_CR5","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1128\/AAC.02472-14","volume":"58","author":"J Cheruiyot","year":"2014","unstructured":"Cheruiyot J, Ingasia LA, Omondi AA et al (2014) Polymorphisms in Pf mdr1, Pf crt, and Pf nhe1 genes are associated with reduced in vitro activities of quinine in Plasmodium falciparum isolates from Western Kenya. Antimicrob Agents Chemother 58:3737\u20133743. https:\/\/doi.org\/10.1128\/AAC.02472-14","journal-title":"Antimicrob Agents Chemother"},{"key":"11022_CR6","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1021\/cb300454t","volume":"8","author":"JM Combrinck","year":"2013","unstructured":"Combrinck JM, Mabotha TE, Ncokazi KK et al (2013) Insights into the role of heme in the mechanism of action of antimalarials. ACS Chem Biol 8:133\u2013137. https:\/\/doi.org\/10.1021\/cb300454t","journal-title":"ACS Chem Biol"},{"key":"11022_CR7","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12936-019-2833-8","volume":"18","author":"TM Dokunmu","year":"2019","unstructured":"Dokunmu TM, Adjekukor CU, Yakubu OF et al (2019) Asymptomatic malaria infections and Pfmdr1 mutations in an endemic area of Nigeria. Malar J 18:218. https:\/\/doi.org\/10.1186\/s12936-019-2833-8","journal-title":"Malar J"},{"key":"11022_CR8","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1017\/S0031182096008487","volume":"114","author":"MT Duraisingh","year":"1997","unstructured":"Duraisingh MT, Drakeley CJ, Muller O et al (1997) Evidence for selection for the tyrosine-86 allele of the pfmdr 1 gene of Plasmodium falciparum by chloroquine and amodiaquine. Parasitology 114:205\u2013211","journal-title":"Parasitology"},{"key":"11022_CR9","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/S1097-2765(05)00077-8","volume":"6","author":"DA Fidock","year":"2000","unstructured":"Fidock DA, Nomura T, Talley AK et al (2000) Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell 6:861\u2013871","journal-title":"Mol Cell"},{"key":"11022_CR10","unstructured":"FMOH (2005) National anti-malaria treatment policy"},{"key":"11022_CR11","unstructured":"FMOH-NMEP (2011) National Guidelines on diagnosis & treatment of malaria in Nigeria June 2011."},{"key":"11022_CR12","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.actatropica.2011.08.013","volume":"120","author":"OA Folarin","year":"2011","unstructured":"Folarin OA, Bustamante C, Gbotosho GO et al (2011) In vitro amodiaquine resistance and its association with mutations in pfcrt and pfmdr1 genes of Plasmodium falciparum isolates from Nigeria. Acta Trop 120:224\u2013230","journal-title":"Acta Trop"},{"key":"11022_CR13","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/345255a0","volume":"345","author":"SJ Foote","year":"1990","unstructured":"Foote SJ, Kyle DE, Martin RK et al (1990) Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Nature 345:255\u2013258","journal-title":"Nature"},{"key":"11022_CR14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ddtec.2014.03.002","volume":"11","author":"F-J Gamo","year":"2014","unstructured":"Gamo F-J (2014) Antimalarial drug resistance: new treatments options for Plasmodium. Drug Discov Today Technol 11:81\u201388","journal-title":"Drug Discov Today Technol"},{"key":"11022_CR15","doi-asserted-by":"publisher","DOI":"10.1590\/S0074-02762012000100018","author":"GA Gauri Awasthi","year":"2012","unstructured":"Gauri Awasthi GA, Prasad G, Aparup Das AD (2012) Pfcrt haplotypes and the evolutionary history of chloroquine-resistant Plasmodium falciparum. Mem Inst Oswaldo Cruz. https:\/\/doi.org\/10.1590\/S0074-02762012000100018","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"11022_CR16","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/1475-2875-13-120","volume":"13","author":"L Golassa","year":"2014","unstructured":"Golassa L, Enweji N, Erko B et al (2014) High prevalence of pfcrt-CVIET haplotype in isolates from asymptomatic and symptomatic patients in south-central Oromia, Ethiopia. Malar J 13:120. https:\/\/doi.org\/10.1186\/1475-2875-13-120","journal-title":"Malar J"},{"key":"11022_CR17","doi-asserted-by":"publisher","first-page":"155","DOI":"10.4269\/ajtmh.2006.75.155","volume":"75","author":"CT Happi","year":"2006","unstructured":"Happi CT, Gbotosho GO, Folarin OA et al (2006) Association between mutations in Plasmodium falciparum chloroquine resistance transporter and P. falciparum multidrug resistance 1 genes and in vivo amodiaquine resistance in P. falciparum malaria-infected children in Nigeria. Am J Trop Med Hyg 75:155","journal-title":"Am J Trop Med Hyg"},{"key":"11022_CR18","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1128\/AAC.00968-08","volume":"53","author":"CT Happi","year":"2009","unstructured":"Happi CT, Gbotosho GO, Folarin OA et al (2009) Selection of Plasmodium falciparum multidrug resistance gene 1 alleles in asexual stages and gametocytes by Artemether-Lumefantrine in Nigerian children with uncomplicated falciparum malaria. Antimicrob Agents Chemother 53:888\u2013895. https:\/\/doi.org\/10.1128\/AAC.00968-08","journal-title":"Antimicrob Agents Chemother"},{"key":"11022_CR19","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.meegid.2005.09.001","volume":"6","author":"G Holmgren","year":"2006","unstructured":"Holmgren G, Gil JP, Ferreira PM et al (2006) Amodiaquine resistant Plasmodium falciparum malaria in vivo is associated with selection of pfcrt 76T and pfmdr1 86Y. Infect Genet Evol 6:309\u2013314","journal-title":"Infect Genet Evol"},{"key":"11022_CR20","doi-asserted-by":"publisher","DOI":"10.1111\/tmi.13273","author":"U Igbasi","year":"2019","unstructured":"Igbasi U, Oyibo W, Omilabu S et al (2019) Kelch 13 propeller gene polymorphism among Plasmodium falciparum isolates in Lagos, Nigeria: molecular epidemiologic study. Trop Med Int Health. https:\/\/doi.org\/10.1111\/tmi.13273","journal-title":"Trop Med Int Health"},{"key":"11022_CR21","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/s12936-019-2977-6","volume":"18","author":"MN Ikegbunam","year":"2019","unstructured":"Ikegbunam MN, Nkonganyi CN, Thomas BN et al (2019) Analysis of Plasmodium falciparum Pfcrt and Pfmdr1 genes in parasite isolates from asymptomatic individuals in Southeast Nigeria 11 years after withdrawal of chloroquine. Malar J 18:343. https:\/\/doi.org\/10.1186\/s12936-019-2977-6","journal-title":"Malar J"},{"key":"11022_CR22","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1056\/NEJMoa062032","volume":"355","author":"MK Laufer","year":"2006","unstructured":"Laufer MK, Thesing PC, Eddington ND et al (2006) Return of chloroquine antimalarial efficacy in Malawi. N Engl J Med 355:1959\u20131966. https:\/\/doi.org\/10.1056\/NEJMoa062032","journal-title":"N Engl J Med"},{"key":"11022_CR23","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/brv.12565","volume":"95","author":"RE Martin","year":"2020","unstructured":"Martin RE (2020) The transportome of the malaria parasite. Biol Rev 95:305\u2013332. https:\/\/doi.org\/10.1111\/brv.12565","journal-title":"Biol Rev"},{"key":"11022_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/7071383","volume":"2018","author":"MN Moyeh","year":"2018","unstructured":"Moyeh MN, Njimoh DL, Evehe MS et al (2018) Effects of drug policy changes on evolution of molecular markers of Plasmodium falciparum resistance to chloroquine, amodiaquine, and sulphadoxine-pyrimethamine in the South West Region of Cameroon. Malar Res Treat 2018:1\u20137. https:\/\/doi.org\/10.1155\/2018\/7071383","journal-title":"Malar Res Treat"},{"key":"11022_CR25","unstructured":"Muhammad RH, Nock IH, Ndams IS, et al (2017) Distribution of Pfmdr1 and Pfcrt chloroquine drug resistance alleles in north-western Nigeria. MalariaWorld J"},{"key":"11022_CR26","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ijpddr.2021.06.001","volume":"16","author":"L Ndwiga","year":"2021","unstructured":"Ndwiga L, Kimenyi KM, Wamae K et al (2021) A review of the frequencies of Plasmodium falciparum Kelch 13 artemisinin resistance mutations in Africa. Int J Parasitol Drugs Drug Resist 16:155\u2013161. https:\/\/doi.org\/10.1016\/j.ijpddr.2021.06.001","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"11022_CR27","unstructured":"NPC-NMCP-ICF 2012 National Population Commission (NPC) [Nigeria], National Malaria Control Programme (NMCP) [Nigeria], and ICF International (2012) Nigeria Malaria Indicator Survey 2010. Abuja, Nigeria: NPC, NMCP, and ICF International"},{"key":"11022_CR28","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13000-015-0276-2","volume":"10","author":"OO Oladipo","year":"2015","unstructured":"Oladipo OO, Wellington OA, Sutherland CJ (2015) Persistence of chloroquine-resistant haplotypes of Plasmodium falciparum in children with uncomplicated Malaria in Lagos, Nigeria, four years after change of chloroquine as first-line antimalarial medicine. Diagn Pathol 10:41. https:\/\/doi.org\/10.1186\/s13000-015-0276-2","journal-title":"Diagn Pathol"},{"key":"11022_CR29","doi-asserted-by":"publisher","DOI":"10.5281\/zenodo.10878545","author":"YA Olukosi","year":"2014","unstructured":"Olukosi YA, Oyebola MK, Ajibaye O et al (2014) Persistence of markers of chloroquine resistance among P. falciparum isolates recovered from two Nigerian communities. MalariaWorld J. https:\/\/doi.org\/10.5281\/zenodo.10878545"},{"key":"11022_CR30","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12936-024-05088-6","volume":"23","author":"KM Oyebola","year":"2024","unstructured":"Oyebola KM, Ligali FC, Owoloye AJ et al (2024) Assessing the therapeutic efficacy of artemether-lumefantrine for uncomplicated malaria in Lagos, Nigeria: a comprehensive study on treatment response and resistance markers. Malar J 23:261. https:\/\/doi.org\/10.1186\/s12936-024-05088-6","journal-title":"Malar J"},{"key":"11022_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.668574","author":"AT Roux","year":"2021","unstructured":"Roux AT, Maharaj L, Oyegoke O et al (2021) Chloroquine and sulfadoxine-pyrimethamine resistance in Sub-Saharan Africa\u2014a review. Front Genet. https:\/\/doi.org\/10.3389\/fgene.2021.668574","journal-title":"Front Genet"},{"key":"11022_CR32","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1186\/s13104-020-05334-5","volume":"13","author":"M Tola","year":"2020","unstructured":"Tola M, Ajibola O, Idowu ET et al (2020) Molecular detection of drug resistant polymorphisms in Plasmodium falciparum isolates from Southwest, Nigeria. BMC Res Notes 13:497. https:\/\/doi.org\/10.1186\/s13104-020-05334-5","journal-title":"BMC Res Notes"},{"key":"11022_CR33","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1038\/s41591-020-1005-2","volume":"26","author":"A Uwimana","year":"2020","unstructured":"Uwimana A, Legrand E, Stokes BH et al (2020) Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda. Nat Med 26:1602\u20131608. https:\/\/doi.org\/10.1038\/s41591-020-1005-2","journal-title":"Nat Med"},{"key":"11022_CR34","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.tips.2006.09.005","volume":"27","author":"SG Valderramos","year":"2006","unstructured":"Valderramos SG, Fidock DA (2006) Transporters involved in resistance to antimalarial drugs. Trends Pharmacol Sci 27:594\u2013601","journal-title":"Trends Pharmacol Sci"},{"key":"11022_CR35","doi-asserted-by":"publisher","first-page":"e20212","DOI":"10.1371\/journal.pone.0020212","volume":"6","author":"MI Veiga","year":"2011","unstructured":"Veiga MI, Ferreira PE, J\u00f6rnhagen L et al (2011) Novel polymorphisms in Plasmodium falciparum ABC transporter genes are associated with major ACT antimalarial drug resistance. PLoS ONE 6:e20212","journal-title":"PLoS ONE"},{"key":"11022_CR36","volume-title":"Basic laboratory methods in medical parasitology","author":"WHO","year":"1992","unstructured":"WHO (1992) Basic laboratory methods in medical parasitology. World Health Organization, Geneva"},{"key":"11022_CR37","volume-title":"Report on antimalarial drug efficacy, resistance and response: 10 years of surveillance (2010\u20132019)","author":"WHO","year":"2020","unstructured":"WHO (2020a) Report on antimalarial drug efficacy, resistance and response: 10 years of surveillance (2010\u20132019), 1st edn. World Health Organization, Geneva","edition":"1"},{"key":"11022_CR38","unstructured":"WHO (2020b) World malaria report 2020. https:\/\/www.who.int\/publications\/i\/item\/9789240015791."},{"key":"11022_CR39","unstructured":"WHO (2023) World malaria report 2023"},{"key":"11022_CR40","unstructured":"WHO-UCN-GMP-2023.01-eng.pdf"},{"key":"11022_CR41","unstructured":"World data info https:\/\/www.worlddata.info\/africa\/nigeria\/climate-lagos.php"},{"key":"11022_CR42","unstructured":"World malaria report 2023. https:\/\/www.who.int\/teams\/global-malaria-programme\/reports\/world-malaria-report-2023"}],"container-title":["Biochemical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-025-11022-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10528-025-11022-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-025-11022-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T05:17:29Z","timestamp":1770441449000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10528-025-11022-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,22]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["11022"],"URL":"https:\/\/doi.org\/10.1007\/s10528-025-11022-5","relation":{"references":[{"id-type":"doi","id":"10.5281\/zenodo.10878545","asserted-by":"subject"}]},"ISSN":["0006-2928","1573-4927"],"issn-type":[{"value":"0006-2928","type":"print"},{"value":"1573-4927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,22]]},"assertion":[{"value":"5 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study received ethical approval from the Research Grants and Experimentation Ethics Committee at the College of Medicine, University of Lagos, Nigeria (CM\/COM\/08\/VOL.XXIV), and the Ethics Committee of the National Institute of Parasitic Diseases (NIPD), Chinese Center for Disease Control and Prevention, Shanghai, People\u2019s Republic of China (Reference Number: 201202019).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The participants were informed about the study protocol and long-term storage of the samples for further studies. They were assured of their right to willingly participate or withdraw from the study at any stage, without impacting the standard care they were entitled to receive at the health facilities. Following this explanation, informed written consent was obtained from the participants. Participants diagnosed with malaria received treatment following the national guidelines outlined by the National Malaria Elimination Program (NMEP). A controlled cabinet was utilized to store all consent documents and other study materials securely.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}